
Quarterly Result14 Nov 2026, 05:24 pm
Nath Bio-Genes Declares Unaudited Financial Results for Q2 FY27
AI Summary
Nath Bio-Genes (India) Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results during a meeting held on November 14, 2026. The company also provided limited review reports from its statutory auditors. The financial information will be available on the company's website.
Key Highlights
- Unaudited standalone and consolidated financial results declared.
- Results are for the quarter and half-year ended September 30, 2026.
- Board of Directors approved the financial results.
- Limited Review Reports from statutory auditors are enclosed.
- Financials will be hosted on the company's website.
Price Impact
More from NATHBIOGEN